Esophagectomy is the surgical removal of part or all of the esophagus, most commonly performed to treat esophageal cancer. It remains one of the most complex operations in general surgery, involving work in the abdomen, chest, and sometimes the neck. Over the past century the procedure has evolved from a near-fatal endeavor to a highly refined operation, but it still carries real risks and a long recovery that reshape how a person eats and lives for months or years afterward.
When Esophagectomy Is Recommended
The primary reason for esophagectomy is esophageal cancer that has invaded beyond the surface lining of the esophagus. Surgery is also considered for high-grade precancerous changes and early-stage tumors arising in Barrett’s esophagus, a condition in which chronic acid reflux transforms the normal lining into a type more vulnerable to cancer.1PubMed. The role of surgery in the management of Barrett’s esophagus (from dysplasia to cancer) Occasionally, the operation is performed for noncancer reasons such as severe esophageal injury from caustic ingestion or a nonfunctional esophagus that cannot be managed any other way, though these situations are far less common.
Not everyone with esophageal cancer is a candidate. The decision depends on where the tumor sits, how far it has spread, and whether the patient can physically tolerate a long operation and a demanding recovery. A thorough workup including imaging, staging, nutritional assessment, and cardiopulmonary testing helps the surgical team decide whether the benefits of removing the tumor outweigh the risks of the operation itself.
Preoperative Treatment Before Surgery
For tumors that have grown beyond the earliest stages, most patients receive treatment before surgery to shrink the cancer and improve the chances of a complete removal. This treatment falls into two broad categories: chemotherapy alone, or chemotherapy combined with radiation (chemoradiation). Both approaches aim to make the tumor smaller and kill any microscopic cancer cells that may have spread, but they differ in how often they succeed at eliminating the tumor entirely.
A large national database study found that patients who received chemoradiation before surgery were roughly three times as likely to have no detectable cancer left in the removed specimen, compared with those who had chemotherapy alone. That complete pathologic response rate was about 17% with chemoradiation versus about 6% with chemotherapy alone, and patients who achieved it survived substantially longer.2PubMed Central. Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients Chemoradiation also led to fewer cases where cancer was found at the edges of the surgical specimen, which matters because positive margins raise the risk of recurrence. Despite those advantages, the choice between the two is not always straightforward: in that same analysis, long-term survival was not independently different between the two groups after accounting for other factors.3PubMed Central. Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients A smaller single-institution series echoed that pattern, reporting higher complete response rates with chemoradiation but no clear survival difference between the two strategies.4PubMed. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer
This nuance shapes real conversations between patients and their oncologists. Chemoradiation is harder on the body than chemotherapy alone, so the added toxicity matters. For many patients the higher chance of a complete response tips the balance, but for those who are frailer, chemotherapy alone may be the wiser path.
The Main Surgical Approaches
Once the decision to operate is made, the surgeon chooses an approach based on where the tumor sits, how much esophagus needs to be removed, and where the new connection between the remaining esophagus and the replacement organ will be placed. The three most established techniques each have different incision sites and reconstruct the digestive tract at different levels.
- Ivor Lewis: The surgeon works through the abdomen and right chest, removing the lower esophagus and creating the new connection (anastomosis) inside the chest. It is widely used for tumors of the lower esophagus and the junction where the esophagus meets the stomach.
- McKeown (three-field): This approach adds a neck incision, allowing the surgeon to remove more of the esophagus and place the anastomosis in the neck. It gives better access to upper esophageal tumors and allows a more thorough removal of lymph nodes along the esophagus.
- Transhiatal: The esophagus is removed through the abdomen and neck without opening the chest. Because it avoids a thoracotomy, it tends to be less traumatic to the lungs, though the surgeon has less direct visibility of the middle esophagus.
Each approach carries distinct trade-offs when things go wrong. A Dutch nationwide study of over 1,000 patients who developed an anastomotic leak found that the transhiatal approach had a lower reoperation rate (about 24%) compared with roughly 41% for both McKeown and Ivor Lewis procedures. ICU readmission after a leak was also lower with transhiatal surgery. Mortality rates with a leak were numerically lower for transhiatal patients, though the difference did not reach statistical significance.5SpringerLink / World Journal of Surgery. Outcomes of Patients with Anastomotic Leakage After Transhiatal, McKeown or Ivor Lewis Esophagectomy: A Nationwide Cohort Study That lower complication burden after a leak reflects the advantage of having the connection in the neck rather than inside the chest, where a leak is harder to manage.
Minimally Invasive and Robotic Techniques
Open esophagectomy through large incisions has gradually given way to minimally invasive approaches that use small ports and cameras. A multicenter prospective study comparing minimally invasive esophagectomy to open surgery reported less blood loss, shorter hospital stays, and more lymph nodes harvested in the minimally invasive group, with no increase in major complications or death. Three-year overall survival was actually higher in the minimally invasive group, reaching about 77% versus 69% for open surgery.6PubMed Central. Minimally invasive versus open esophagectomy for resectable thoracic esophageal cancer (NST 1502): a multicenter prospective cohort study Earlier comparative work had already confirmed that cancer outcomes were not compromised by the smaller incisions.7PubMed Central. Comparison of the Outcomes Between Open and Minimally Invasive Esophagectomy
Robotic surgery takes the minimally invasive concept further by giving the surgeon a three-dimensional, high-definition view and mechanical wrist-like instruments that move more precisely than rigid laparoscopic tools.8PubMed Central. Extended thoracic lymph node dissection in robotic-assisted minimal invasive esophagectomy (RAMIE) for patients with superior mediastinal lymph node metastasis One area where the robot seems to shine is lymph node dissection around the recurrent laryngeal nerve, a delicate structure in the upper chest and neck that controls the vocal cords. Robotic-assisted surgery harvested more lymph nodes in that area with a lower rate of nerve injury compared with conventional minimally invasive surgery.9PubMed Central. Lymph node dissection around left recurrent laryngeal nerve: robot-assisted vs. video-assisted McKeown esophagectomy for esophageal squamous cell carcinoma Despite these procedural advantages, overall survival and disease-free survival have not clearly separated between robotic and conventional minimally invasive approaches so far.10Laparoscopic, Endoscopic and Robotic Surgery. The clinical application and advancement of robot-assisted McKeown minimally invasive esophagectomy for esophageal cancer
Rebuilding the Digestive Tract
Once the esophagus is removed, something has to take its place so food can travel from the throat to the intestines. In most cases, the stomach is reshaped into a narrow tube, sometimes called a gastric conduit, and pulled up into the chest or neck to reconnect with the remaining esophagus. When the stomach is not available, the colon or a segment of small intestine (jejunum) can be used instead.
A systematic review and network meta-analysis comparing these options found that the free jejunal flap had the lowest probability of anastomotic leakage, while colon interposition carried the highest. For narrowing at the connection site (stricture), the colon performed best and the gastric pull-up was most prone to it. Hospital stays tended to be shortest with the gastric pull-up.11PubMed Central. A Comparison of Different Types of Esophageal Reconstructions: A Systematic Review and Network Meta-Analysis In practice, the gastric conduit remains the default because of its reliable blood supply, straightforward surgical technique, and shorter operative time. The alternatives are reserved for patients whose stomach has been previously removed or is otherwise unusable.
Complications and What Drives Them
Anastomotic leakage, where the surgical connection between the new conduit and the remaining esophagus fails to heal properly, is the most feared complication. It is linked to increased time in the hospital, repeat operations, and a higher chance of dying.12PubMed Central. Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment A range of factors contribute, from a patient’s underlying health to how well blood reaches the new connection and the specific surgical technique used.13PubMed Central. Anastomotic Leak After Esophagectomy: Modern Approaches to Prevention and Diagnosis Detecting a leak early can be tricky because symptoms vary widely; surgeons rely on a combination of clinical signs, blood markers of inflammation, imaging, and sometimes endoscopy.
Lung complications are the other major concern. Acute lung injury after esophagectomy occurs in roughly one in ten patients, and when it develops it extends hospital stays, raises costs, and increases the risk of death.14PubMed. Risk of Acute Lung Injury after Esophagectomy The lung on the side of the surgery is more affected than the opposite lung, and longer operations correlate with a greater risk.15Journal of Cancer Research and Therapeutics. Clinical analysis of acute lung injury after esophagectomy The shift toward minimally invasive surgery, which avoids cracking the ribs or spreading them widely, is partly motivated by the desire to reduce this particular problem.
Recovery and Enhanced Recovery Protocols
Hospital stays after esophagectomy have shortened considerably thanks to structured recovery programs. These enhanced recovery after surgery (ERAS) protocols bundle together dozens of evidence-based care steps, including early mobilization, careful fluid management, prompt removal of drains and lines, and early involvement of dietitians. A high-volume center that tracked outcomes across successive implementation phases found median hospital stays dropped from 16 days before ERAS adoption to 11 days afterward, and complication rates fell from about 81% to 74%.16Journal of Gastrointestinal Surgery. Implementation of an enhanced recovery after surgery protocol for esophagectomy: an evaluation in a high-volume tertiary center Another study reported roughly five fewer days in the hospital and over two fewer days in the ICU under an ERAS protocol, with no difference in complication rates and comparable three-year survival.17PubMed Central. Impact of the enhanced recovery after surgery (ERAS) protocol on 3-year survival and outcomes following esophagectomy: a retrospective cohort study of 124 patients
The value of physical preparation before surgery, often called prehabilitation, has also become clearer. Patients typically lose fitness during neoadjuvant chemotherapy, but a supervised exercise and nutrition program during that window can reverse much of the decline. A randomized trial of older patients found that those who received both exercise and nutritional support during preoperative chemotherapy maintained or slightly gained skeletal muscle mass, while those with no prehabilitation lost muscle.18PubMed Central. Exercise and Nutrition Prehabilitation Program During Preoperative Chemotherapy Followed by Esophagectomy in Older Patients With Esophageal Cancer: A Randomized Clinical Trial Another study confirmed that fitness markers declined during neoadjuvant treatment but improved during a prehabilitation interval before surgery.19PubMed. The course of physical fitness and nutritional status in patients following prehabilitation before esophageal cancer surgery: Results from the PRIOR study Going into a major operation in better physical shape is one of the few things patients can actively influence.
Life After Esophagectomy
Surviving the operation is only half the story. The reshaped digestive tract works differently from the original, and most patients deal with a cluster of functional symptoms that can persist for years. Dumping syndrome, where food moves too quickly from the stomach replacement into the small intestine, is by far the most common. One study found that roughly 78% of patients experienced dumping at least once in the first year, and at any given follow-up visit about 40 to 45% had active symptoms.20PubMed. Dumping Syndrome After Esophagectomy: Prevalence and Predictors in Gastroesophageal Cancer Patients Symptoms include cramping, sweating, lightheadedness, and diarrhea within minutes of eating, particularly after sugary or high-carbohydrate meals. In long-term survivors, about one in five still reported at least moderately severe problems from dumping, and nearly half had changed their diet to manage it.21PubMed Central. Post-Esophagectomy Dumping Syndrome: Assessing Quality of Life of Long-Term Survivors
Other common functional issues include difficulty swallowing (often from narrowing at the surgical connection, which can be stretched during endoscopy), reflux of stomach contents into the throat, delayed emptying of the gastric conduit, chronic diarrhea, and significant weight loss.22PubMed Central. Functional syndromes and symptom-orientated aftercare after esophagectomy Most patients lose 10 to 15% of their preoperative weight and struggle to regain it, partly because the smaller stomach replacement limits meal size and partly because nutrient absorption changes.
The encouraging news is that quality of life does recover. A longitudinal study tracking patient-reported outcomes found that overall quality of life dropped in the first three months after surgery but then steadily climbed. By three years it had returned to preoperative levels, and by five years it exceeded them. General well-being scores, which were lower than the general population before surgery (as you might expect in people diagnosed with cancer), matched population norms by the three-year mark.23The Annals of Thoracic Surgery. Long-Term Quality of Life After Esophagectomy for Esophageal Cancer The initial dip is driven mostly by eating difficulties and reduced physical function, both of which gradually improve as the body adapts to its new anatomy.
Why the Hospital You Choose Matters
Esophagectomy is one of those operations where experience is not just helpful but measurable. A meta-analysis of 56 studies including nearly 400,000 patients found that higher-volume hospitals cut the risk of dying after surgery by about half compared with lower-volume hospitals. Mortality rates dropped steeply as hospital volume rose, declining from roughly 24% at the lowest-volume centers to about 6% once a hospital was performing around 45 esophagectomies a year, and stabilizing near 5% beyond 70 cases per year.24PubMed Central. Hospital volume-mortality association after esophagectomy for cancer: a systematic review and meta-analysis A population-based English study found that each additional esophagectomy a surgeon performed reduced 30-day mortality odds by about 3%.25Annals of Surgery. Surgeon Volume and Cancer Esophagectomy, Gastrectomy, and Pancreatectomy: A Population-based Study in England
These numbers have driven a push in many countries to centralize esophageal cancer surgery into high-volume referral centers with dedicated teams of surgeons, anesthesiologists, intensivists, and specialized nurses.26Surgery Open Science. Prediction of mortality after esophagectomy: A comprehensive analysis of various risk scores in a national esophageal center If you or a family member faces this surgery, asking about the center’s annual case volume is one of the most practical questions you can raise.
When Surgery Is Not the Only Path
For some patients, definitive chemoradiation without any surgery is a real alternative. A propensity-matched comparison found that esophagectomy alone offered significantly better survival than chemoradiation for early-stage disease, with three-year survival rates of about 46% versus 26%. For patients with more advanced (stage III) disease, however, the survival difference between the two strategies vanished.27The Annals of Thoracic Surgery. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer In early-stage squamous cell carcinoma specifically, chemoradiation produced overall survival comparable to surgery, even though local recurrence was higher; most recurrences could be treated endoscopically without affecting long-term survival.28PubMed. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma
The growing interest in organ preservation, where patients who respond completely to chemoradiation skip surgery entirely, has fueled research into better ways to detect residual cancer. A recent study showed that a personalized blood test for circulating tumor DNA could detect remaining cancer after chemoradiation with about 73% sensitivity on its own, and when combined with conventional endoscopic methods that sensitivity rose above 92%.29Cell Reports Medicine. Circulating tumor DNA guides neoadjuvant and adjuvant management of esophageal squamous cell carcinoma Tools like this may eventually allow doctors to confidently identify which patients can safely avoid an esophagectomy after responding well to chemoradiation, sparing them a major operation and its lifelong functional consequences.
How the Operation Has Changed Over a Century
The first successful esophageal resection was performed by Franz Torek in 1913, and for decades afterward the operation carried a staggering mortality rate. It took nearly twenty years before similar successes were replicated, and the procedure evolved slowly through different chest approaches, the introduction of mechanical staplers in the mid-twentieth century, and steady improvements in anesthesia and intensive care.30PubMed Central. Milestones in the History of Esophagectomy: From Torek to Minimally Invasive Approaches By the second half of the twentieth century, better surgical technique and perioperative management had driven mortality down substantially.31PubMed Central. History of esophagectomy for cancer of the esophagus and the gastroesophageal junction
The introduction of minimally invasive techniques in the 1990s and robotic platforms in the 2000s continued that trajectory. International collaborative efforts have standardized how outcomes are measured and reported, making it easier to compare results across centers and identify best practices. The operation patients undergo today bears little resemblance to what Torek performed, but the fundamental challenge remains the same: removing a diseased organ from the center of the body and restoring a functional path for food, with as little collateral damage as possible.